Practicability and efficacy of training with the Galileo vibration platform in neuromuscular disease

Not Applicable

• Conditions: G12.1; G71.0; Other inherited spinal muscular atrophy; Muscular dystrophy

• Registration Number: DRKS00000436
• Lead Sponsor: niversitätsklinikum FreiburgZentrum für Kinder- und Jugendmedizin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-10-11
• Study Completion: 2011-11-09
• Results First Posted: 2013-10-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 22

Inclusion Criteria

boys with diagnosis DMD (approved by gene test or musclebiopsy)
-boys and girls with SMA Type III (approved by gene test )
-age = 5 years and = 18 years
-able to walk 10m without assistance
-able to stand on Galileo apparat
-compliance of the patient
-signed informed consent (parents and patient)

Exclusion Criteria

. contractures which made the therapy with Galileo impractical
. change of therapy within 3 month prior study
. fracture within 6 month prior study
. acute inflammation of the motoric system
. acute thrombosis within 6 month
. kidney stone, gallstone
. hernia
. acute trauma at feet
. operation within 3 month prior study
. pregnancy
. implants
. seizures

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Practicability of training with the Galileo Vibration Platlet in children and adolescent with DMD and SMA III

Secondary Outcome Measures

Name	Time	Method
Efficacy of the training after 2 month in:<br>muscle function (improve of 6MWT (=6 Minute Walking Test)measured at baseline and week 8),muscle strengt(measured at baseline and week 8 by MRC Scale =Medical Research Counsil Scale), quality of life(measured at baseline and week 8 by Peds QL= Pediatric Quality of Life), metabolism of bone (measured at baseline and week 8 by blood markers).<br>